Filing Flows

Filing Flows › Companies › OneMedNet › Cash flow

OneMedNet cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$1.9M in Q2 2026 · −$6.9M over twelve months

Operating cash flow−$1.9M
Capital spending−$9K
Free cash flow−$1.9M
Cash conversion cycle-182 days

Analysis

In Q2 2026, OneMedNet generated −$1.9M of operating cash flow and spent $9K on capital projects, leaving free cash flow of −$1.9M. That is $308K more than in Q2 2025 (−$2.2M).

Over the twelve months to Jun 30, 2026, operating cash flow was −$6.9M; the largest uses were operating cash flow ($6.9M), net borrowing (+) / repaid (−) ($485K), capital spending ($16K); besides operations, cash came from other financing ($6.1M), other investing ($1.5M); the cash balance rose by $236K.

Operating cash flow was −$1.9M against net income of −$2.2M. The largest differences: stock-based pay +$463K, payables −$285K, receivables +$33K.

Its cash conversion cycle was -182 days (receivables 212 + inventory 0 − payables 394): suppliers fund its working capital.

Free cash flow

OneMedNet: free cash flow by quarterOneMedNet: free cash flow by quarter−$1.9MQ3 2024−$2.0MQ4 2024−$1.9MQ1 2025−$2.2MQ2 2025−$1.7MQ3 2025−$1.7MQ4 2025−$1.5MQ1 2026−$1.9MQ2 2026
Operating cash flow less capital spending.
OneMedNet: operating cash flow against capital spendingOneMedNet: operating cash flow against capital spendingOperating cash flowCapital spending−$1.9M$9KQ3 2024−$2.0M$35KQ4 2024−$1.9M$5KQ1 2025−$2.2M$3KQ2 2025−$1.7M$0Q3 2025−$1.7M$5KQ4 2025−$1.5M$2KQ1 2026−$1.9M$9KQ2 2026
Latest (Q2 2026): Operating cash flow −$1.9M, Capital spending $9K.

Capital allocation, year by year

OneMedNet: where the cash came from (up) and went (down), by fiscal yearOneMedNet: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingFY2022: Operating cash flow −$4.7MFY2022: Net borrowing $5.1MFY2022: Shares issued $8KFY2022: Capital spending −$58K$5.1MFY2022FY2023: Operating cash flow −$4.8MFY2023: Net borrowing $4.2MFY2023: Shares issued $16KFY2023: Capital spending −$44K$4.2MFY2023FY2024: Operating cash flow −$7.0MFY2024: Net borrowing $1.1MFY2024: Capital spending −$51K$1.1MFY2024FY2025: Operating cash flow −$7.5MFY2025: Net borrowing −$401KFY2025: Capital spending −$13KFY2025
Over these 4 years operating cash flow totalled −$23.9M; the largest uses were operating cash flow ($23.9M) and net borrowing ($401K). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$358K
Debt$132K
Net cash$226K
Cash runway1 month

OneMedNet is burning cash: its operations consume cash, a free cash flow of −$6.9M a year at the current rate against $358K of cash and investments: a runway of about 1 month before any new financing.

Where the cash came from and went

OneMedNet: sources (+) and uses (−) of cash, Q2 2026OneMedNet: sources (+) and uses (−) of cash, Q2 2026Other financing$2.1MOperating cash flow−$1.9MNet borrowing (+) / repaid (−)−$136KCash drawn (+) / kept (−)−$125KOther investing$65KCapital spending−$9K
OneMedNet: sources (+) and uses (−) of cash, TTM to Q2 2026OneMedNet: sources (+) and uses (−) of cash, TTM to Q2 2026Operating cash flow−$6.9MOther financing$6.1MOther investing$1.5MNet borrowing (+) / repaid (−)−$485KCash drawn (+) / kept (−)−$236KCapital spending−$16K

From profit to cash

OneMedNet: net income to operating cash flow, Q2 2026OneMedNet: net income to operating cash flow, Q2 2026Net income−$2.2MStock-based pay$463KReceivables$33KPayables−$285KDeferred revenue$4KOperating cash flow−$1.9M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q2 2026212—394-182
Q1 2026559—703-144
Q4 202556—406-350
Q3 2025217—519-302
Q1 2025151—1609-1458
Q4 2024488—10791-10303
Q3 202445—2572-2528

Every quarter

QuarterOperating cash flowCapital spendingNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026−$1.9M−$9K−$136K—−$125K−$1.9M
Q1 2026−$1.5M−$2K−$137K—$352K−$1.5M
Q4 2025−$1.7M−$5K——−$436K−$1.7M
Q3 2025−$1.7M——$500K−$27K−$1.7M
Q2 2025−$2.2M−$3K−$95K—$22K−$2.2M
Q1 2025−$1.9M−$5K−$94K—$28K−$1.9M
Q4 2024−$2.0M−$35K——$1.8M−$2.0M
Q3 2024−$1.9M−$9K−$100K—−$1.2M−$1.9M

OneMedNet: income statement and cash flow

OneMedNet, Q2 2026: revenue $292K (+88% year over year), operating margin -774.3%. The chart follows the revenue to costs, profit and cash.

OneMedNet: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.